BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 23142218)

  • 41. miR-139 Functions as An Antioncomir to Repress Glioma Progression Through Targeting IGF-1 R, AMY-1, and PGC-1β.
    Wang H; Yan X; Ji LY; Ji XT; Wang P; Guo SW; Li SZ
    Technol Cancer Res Treat; 2017 Aug; 16(4):497-511. PubMed ID: 26868851
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MicroRNA-23b functions as an oncogene and activates AKT/GSK3β/β-catenin signaling by targeting ST7L in hepatocellular carcinoma.
    Zhuang L; Wang X; Wang Z; Ma X; Han B; Zou H; Wu Z; Dong S; Qu Z; Zang Y; Wu L
    Cell Death Dis; 2017 May; 8(5):e2804. PubMed ID: 28518144
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human miR-31 targets radixin and inhibits migration and invasion of glioma cells.
    Hua D; Ding D; Han X; Zhang W; Zhao N; Foltz G; Lan Q; Huang Q; Lin B
    Oncol Rep; 2012 Mar; 27(3):700-6. PubMed ID: 22089331
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Upregulated microRNA-301a in breast cancer promotes tumor metastasis by targeting PTEN and activating Wnt/β-catenin signaling.
    Ma F; Zhang J; Zhong L; Wang L; Liu Y; Wang Y; Peng L; Guo B
    Gene; 2014 Feb; 535(2):191-7. PubMed ID: 24315818
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epigenetic silencing of miR-338 facilitates glioblastoma progression by de-repressing the pyruvate kinase M2-β-catenin axis.
    Han B; Meng X; Chen H; Chen L; Liu X; Wang H; Liu D; Gao F; Lin L; Ming J; Sun B; Yin S; Wang R; Wu P; Cai J; Jiang C
    Aging (Albany NY); 2017 Aug; 9(8):1885-1897. PubMed ID: 28858851
    [TBL] [Abstract][Full Text] [Related]  

  • 46. miR-124a restoration inhibits glioma cell proliferation and invasion by suppressing IQGAP1 and β-catenin.
    Lu SH; Jiang XJ; Xiao GL; Liu DY; Yuan XR
    Oncol Rep; 2014 Nov; 32(5):2104-10. PubMed ID: 25175832
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Primate-specific miR-663 functions as a tumor suppressor by targeting PIK3CD and predicts the prognosis of human glioblastoma.
    Shi Y; Chen C; Zhang X; Liu Q; Xu JL; Zhang HR; Yao XH; Jiang T; He ZC; Ren Y; Cui W; Xu C; Liu L; Cui YH; Yu SZ; Ping YF; Bian XW
    Clin Cancer Res; 2014 Apr; 20(7):1803-13. PubMed ID: 24523440
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Knockdown of SOX2OT inhibits the malignant biological behaviors of glioblastoma stem cells via up-regulating the expression of miR-194-5p and miR-122.
    Su R; Cao S; Ma J; Liu Y; Liu X; Zheng J; Chen J; Liu L; Cai H; Li Z; Zhao L; He Q; Xue Y
    Mol Cancer; 2017 Nov; 16(1):171. PubMed ID: 29132362
    [TBL] [Abstract][Full Text] [Related]  

  • 49. miR-124 suppresses the migration and invasion of glioma cells in vitro via Capn4.
    Cai JJ; Qi ZX; Chen LC; Yao Y; Gong Y; Mao Y
    Oncol Rep; 2016 Jan; 35(1):284-90. PubMed ID: 26530859
    [TBL] [Abstract][Full Text] [Related]  

  • 50. miR-548b inhibits the proliferation and invasion of malignant gliomas by targeting metastasis tumor-associated protein-2.
    Pan Y; Liang W; Zhao X; Liu L; Qing Y; Li Y
    Neuroreport; 2016 Dec; 27(17):1266-1273. PubMed ID: 27682888
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MiR-214 inhibits cell growth in hepatocellular carcinoma through suppression of β-catenin.
    Wang X; Chen J; Li F; Lin Y; Zhang X; Lv Z; Jiang J
    Biochem Biophys Res Commun; 2012 Nov; 428(4):525-31. PubMed ID: 23068095
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MicroRNA-9 inhibits the proliferation of oral squamous cell carcinoma cells by suppressing expression of CXCR4 via the Wnt/β-catenin signaling pathway.
    Yu T; Liu K; Wu Y; Fan J; Chen J; Li C; Yang Q; Wang Z
    Oncogene; 2014 Oct; 33(42):5017-27. PubMed ID: 24141785
    [TBL] [Abstract][Full Text] [Related]  

  • 53. TCTP promotes glioma cell proliferation in vitro and in vivo via enhanced β-catenin/TCF-4 transcription.
    Gu X; Yao L; Ma G; Cui L; Li Y; Liang W; Zhao B; Li K
    Neuro Oncol; 2014 Jan; 16(2):217-27. PubMed ID: 24311645
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MiR-200a impairs glioma cell growth, migration, and invasion by targeting SIM2-s.
    Su Y; He Q; Deng L; Wang J; Liu Q; Wang D; Huang Q; Li G
    Neuroreport; 2014 Jan; 25(1):12-7. PubMed ID: 24162743
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interplay between PCBP2 and miRNA modulates ARHGDIA expression and function in glioma migration and invasion.
    Lin X; Yang B; Liu W; Tan X; Wu F; Hu P; Jiang T; Bao Z; Yuan J; Qiang B; Peng X; Han W
    Oncotarget; 2016 Apr; 7(15):19483-98. PubMed ID: 26761212
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway.
    Hsieh IS; Chang KC; Tsai YT; Ke JY; Lu PJ; Lee KH; Yeh SD; Hong TM; Chen YL
    Carcinogenesis; 2013 Mar; 34(3):530-8. PubMed ID: 23188675
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MiR-203 suppresses tumor growth and invasion and down-regulates MiR-21 expression through repressing Ran in esophageal cancer.
    Zhang F; Yang Z; Cao M; Xu Y; Li J; Chen X; Gao Z; Xin J; Zhou S; Zhou Z; Yang Y; Sheng W; Zeng Y
    Cancer Lett; 2014 Jan; 342(1):121-9. PubMed ID: 24001611
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MiR-27a regulates Wnt/beta-catenin signaling through targeting SFRP1 in glioma.
    Wang K; Xie D; Xie J; Wan Y; Ma L; Qi X; Yang S
    Neuroreport; 2015 Aug; 26(12):695-702. PubMed ID: 26164457
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MiR-18a regulates the proliferation, migration and invasion of human glioblastoma cell by targeting neogenin.
    Song Y; Wang P; Zhao W; Yao Y; Liu X; Ma J; Xue Y; Liu Y
    Exp Cell Res; 2014 May; 324(1):54-64. PubMed ID: 24657544
    [TBL] [Abstract][Full Text] [Related]  

  • 60. miR-320a functions as a suppressor for gliomas by targeting SND1 and β-catenin, and predicts the prognosis of patients.
    Li H; Yu L; Liu J; Bian X; Shi C; Sun C; Zhou X; Wen Y; Hua D; Zhao S; Ren L; An T; Luo W; Wang Q; Yu S
    Oncotarget; 2017 Mar; 8(12):19723-19737. PubMed ID: 28160566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.